Atlas Trials

Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer

Clinical trial NCT00521274 · TERMINATED

Trial details

NCT number
NCT00521274
Sponsor
The Methodist Hospital Research Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostatic Neoplasms
Start date
2007-08-01
Primary completion
2008-07-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.